Related Experiment Video

Updated: Apr 23, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K

Understanding basic carbohydrate counting, glycemic index, and glycemic load for improved glycemic control in

Lidia Guadalupe Compeán Ortiz1, Diane C Berry, Octelina Castillo Ruiz

  • 1Autonomous University of Tamaulipas, Tampico, Mexico.

Hispanic Health Care International : the Official Journal of the National Association of Hispanic Nurses
|September 21, 2014
PubMed

Insights

Hispanic patients with type 2 diabetes often struggle with poor glycemic control. Mastering carbohydrate counting, glycemic index, and glycemic load is crucial for managing blood glucose and preventing diabetes complications.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Public Health

Background:

  • Type 2 diabetes mellitus (T2DM) disproportionately affects Hispanic populations, often presenting with suboptimal glycemic control.
  • Persistent hyperglycemia in T2DM is a primary driver of debilitating microvascular and macrovascular complications, increasing morbidity and mortality rates.
  • Achieving effective glycemic management necessitates a multifaceted approach involving diet, exercise, and pharmacotherapy, with dietary adherence posing a significant challenge.

Purpose of the Study:

  • To highlight the critical role of macronutrient management, particularly carbohydrates, in achieving glycemic control for Hispanic patients with T2DM.
  • To emphasize the importance of educating patients on practical dietary strategies for blood glucose regulation.

Main Methods:

  • Review of existing literature on glycemic control in Hispanic populations with T2DM.
  • Analysis of the impact of different macronutrients on blood glucose levels.
  • Evaluation of dietary management tools such as carbohydrate counting, glycemic index, and glycemic load.

Main Results:

  • Carbohydrates exert the most significant influence on postprandial blood glucose levels compared to other macronutrients.
  • Effective implementation of carbohydrate counting, glycemic index, and glycemic load strategies can empower patients to better manage their blood glucose.
  • Dietary interventions are essential but often difficult for patients to sustain without adequate education and support.

Conclusions:

  • Improved understanding and application of carbohydrate-focused dietary strategies are vital for enhancing glycemic control in Hispanic patients with T2DM.
  • Educational interventions focusing on carbohydrate counting, glycemic index, and glycemic load can improve patient self-management and potentially reduce diabetes-related complications.
  • Addressing dietary challenges is a key component in mitigating the health disparities associated with T2DM in the Hispanic community.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

70.0K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
21
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
23
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
945